The EPS projection of EnteroMedics Inc. (NASDAQ:ETRM) for quarter ended 2016-09-30 is $-0.67. A week before, the EPS forecast was $-0.67 against target of $-0.67, a month earlier. This estimate stood at $-0.67 60 days earlier versus forecast of $-0.67 90 days earlier, confirming a deviation of 0%.
EnteroMedics Inc. (NASDAQ:ETRM) reported that 18 days ago, the positive EPS revisions were 1 and negative revisions at 0.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 0, 0, 0 and 0, respectively.
The downgrade of EPS estimates for EnteroMedics Inc. (NASDAQ:ETRM) in the preceding 120, 60, 30 and 90 days were 1, 1, 1 and 1, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of EnteroMedics Inc. (NASDAQ:ETRM) was $-0.67. This projection was computed after accounting 2 calls. As reported on 2016-05-05 the EPS was $-0.82. The change was $-0.02, demonstrating a percentage deviation of -2.5%. The projections confirmed a standard deviation of 0.
Quarterly Sales Estimates
For the fiscal 2016, the yearly sales target for EnteroMedics Inc. (NASDAQ:ETRM) stands at $0.295 and the median estimate at $0.295. Almost 2 analysts announced their estimates.
The highest estimate is $0.39 while the lowest target is $0.2 showing standard deviation of 0.134%.
As many as 2 analysts released sales estimates reised in upside while 2 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 2 revised sales number projection on upside while 2 lowered the sales target, demonstrating a deviation of 47.5%.
A quarter ago, 2 hiked sales estimations and 2 reduced sales forecast. EnteroMedics Inc. (NASDAQ:ETRM) stated that the change in forecast was -47.787%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...